Skip to main content

Global

HKBU joins with Hunan University to establish Hong Kong branch of State Key Laboratory of Chemo/Biosensing and Chemometrics

28 Oct 2013

Professor Lu Aiping (first row, centre), Dean of the School of Chinese Medicine, will serve as the Co-Director of the HKBU Branch of the State Key Laboratory of Chemo/Biosensing and Chemometrics of Hunan University, leading a team in conducting research together with Hunan University
Professor Lu Aiping (first row, centre), Dean of the School of Chinese Medicine, will serve as the Co-Director of the HKBU Branch of the State Key Laboratory of Chemo/Biosensing and Chemometrics of Hunan University, leading a team in conducting research together with Hunan University

The University has recently entered into an agreement with Hunan University to set up the HKBU Branch of the State Key Laboratory of Chemo/Biosensing and Chemometrics (CBC State Key Lab) of Hunan University, which will be the Hong Kong branch of the CBC State Key Lab. The two institutions will work together at the HKBU Branch to conduct research in molecular, biomedical and translational sciences, especially in the fields of systems biology and drug discovery in Chinese medicine.

 

The HKBU Branch will be led by an academic committee comprising Professor Albert Chan, President and Vice-Chancellor of HKBU, Professor Zhang Yugui, Director of the Academic Committee of the CBC State Key Lab, and other renowned experts from China and overseas. Professor Lu Aiping, Dean of the School of Chinese Medicine (SCM), HKBU, and Professor Tan Weihong, Director of the CBC State Key Lab, will serve as the Co-Directors of the HKBU Branch. Researchers of the Branch will come from SCM, the Institute for Advancing Translational Medicine in Bone & Joint Diseases (a joint initiative of SCM and the Faculty of Science, HKBU), and other researchers from HKBU in relevant disciplines as well as from the CBC State Key Lab.

 

Pursuant to the agreement, HKBU and Hunan University will collaborate at the HKBU Branch to conduct research in molecular, biomedical and translational sciences, especially in the fields of systems biology and drug discovery in Chinese medicine. The HKBU Branch aims to discover novel therapeutic drugs with Chinese traditional characteristics from herbs, to establish a platform for developing targeted drugs (combinatory drugs) with efficiency and safety in treating challengeable bone and joint diseases, and cancer and inflammation diseases by modifying natural small molecules using chemical biology (e.g. aptamer technology), and to advance personalised medicine through research in systems biology in Chinese medicine. Furthermore, the HKBU Branch will nurture experts in translational medicine and create an integrative platform for clinical medicine, basic research and fostering talent.

 

Professor Lu Aiping believes that through the collaboration of the two universities on research in molecular, biomedical and translational sciences, the HKBU Branch will be able to produce groundbreaking results that bring health benefits.